A

Arcus Biosciences

Biotechnology · United States · 1,000 employees

164 Decision makers
+4 New (6 months)
1,000 Employees
$117M Revenue
2015 Founded

Organizational Chart of Arcus Biosciences

Roles identified within Arcus Biosciences's leadership team, from public professional data, updated 25 Oct 2026.

Department

Arcus Biosciences's Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Decision makers at Arcus Biosciences by function

General management

Finance

Tech & product

See all Arcus Biosciences contacts on Zeliq

Decision makers at Arcus Biosciences

164 identified 7 C-Level 22 VP 135 Directors +4 new (6 months)
See them on Zeliq →

Departments actively hiring 2 departments

Medical
Operations

These departments at Arcus Biosciences are actively recruiting: a strong signal to time your outreach.

Funding and news at Arcus Biosciences

Funding

Last round Other · $250M
Total funding $1.6B (10 rounds)
Series A $50M May 2015
Series B $70M Sep 2016
Series C $107M Nov 2017
Post-IPO Equity $200M May 2020
Post-IPO Equity $220M Feb 2021
Post-IPO Debt $84M Nov 2021
Post-IPO Equity $320M Jan 2024
Post-IPO Debt $150M Aug 2024
Post-IPO Equity $150M Mar 2025
Post-IPO Equity $250M Oct 2025

Latest news at Arcus Biosciences

  1. Appointment

    New Director appointed — General management

  2. Appointment

    New Associate Director Regulatory Affairs Cmc appointed — Medical

  3. Appointment

    New Associate Director Clinical Operations appointed — Operations

Get these new hires' email and phone →

Team Structure headcount by department

Research
182
Hiring Medical
98
Other
54
General Management
43
Hiring Operations
42
Project Management
25
Finance
22
Legal
21

How to prospect Arcus Biosciences's departments

Research

With 182 people, this is the organisation's biggest team. Researchers respond to substance: reference publications, benchmarks or datasets relevant to their field.

Medical

A team of 98 people, currently hiring. Medical teams trust peer references: name comparable organisations you already serve.

Other

A team of 54 people. Hard to read from the outside: use a first exchange to map who does what before pushing an offer.

General Management

This department counts 43 people. A good executive approach often starts lower in the organisation: build an internal champion before going top-down.

Operations

This 42-person department is actively recruiting. Operations leaders live in the concrete: a pilot scoped on one process will convince more than a demo.

Project Management

25 people work in this department. Deadlines and cross-team coordination are the daily battle: position yourself on predictability and visibility.

Try the Zeliq email finder demo →

FAQ Arcus Biosciences

Who runs Arcus Biosciences?

The highest-ranking leadership role identified at Arcus Biosciences is “CEO”, based on public data updated 25 Oct 2026.

How many decision makers does Arcus Biosciences have?

164 decision makers identified, including 7 at executive level.

How do I contact a decision maker at Arcus Biosciences?

Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.

Which departments are hiring at Arcus Biosciences?

Medical and Operations, based on published job offers as of 25 Oct 2026.

Companies similar to Arcus Biosciences

More companies to explore

Biotechnology · United States

All Biotechnology companies in United States →

About Arcus Biosciences

Arcus Biosciences is a company active in the Biotechnology space, operating from United States. Founded in 2015, the company has a workforce of roughly 1,000 people. As part of the broader Hospitals and Health Care sector, Arcus Biosciences operates specifically in the Biotechnology segment. Arcus Biosciences has raised funding across 10 rounds totalling $1.6B. Annual revenue is estimated at around $117M. The data below (industry, headcount, location and business signals) helps sales teams qualify Arcus Biosciences and pinpoint the right decision makers from the first touchpoint.

Activity & Market

The company evolves in the Biotechnology segment of the Hospitals and Health Care sector. In terms of structure, it is registered as “Public company”.